Pharmacy

Sens. Josh Hawley, R-Mo., and Peter Welch, D-Vt., introduced a bipartisan bill intended to lower prescription drug prices in the U.S. by tying them to international pricing.  The Fair Prescription Drug Prices for Americans Act would prohibit pharmaceutical companies from…

The FDA’s leader of drug and food inspections, imports and investigations abruptly announced he plans to exit the agency next week, according to a May 5 CBS News report.  Michael Rogers, associate commissioner for inspections and investigations, told staff his…

On May 5, President Trump signed an executive order aimed at boosting domestic production of prescription drugs and active ingredients. Six details: 1. In the U.S., bringing new drug manufacturing plants online can take years, “which is unacceptable from a…

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in alphabetical order. 

Santa Barbara, Calif.-based Cottage Health is partnering with Clearway Health to develop a specialty pharmacy program at the three-hospital system.  As part of the collaboration, pharmacists and patient liaisons are integrated into the health system’s specialty clinics to help patients…

President Donald Trump is targeting the pharmaceutical industry as a way to help finance his tax cut plans, pressing House Republicans to force drugmakers to accept lower prices on drugs covered by Medicaid, Bloomberg reported May 2.  The White House…

The Institute for Safe Medication Practices will build the first state-required medication error reporting system for community pharmacies in California following its selection by the California Board of Pharmacy.  The program stems from a law enacted in 2023 that requires…

The American Hospital Association is urging CMS to adjust its newly established drug price negotiation program, arguing the agency’s current approach conflicts with 340B programs.  In a May 1 open letter to Kim Brandt, CMS’ COO, the hospital member group…

The FDA plans to gather information from 250 compounding outsourcing pharmacies amid safety and quality concerns.  In a May 1 notice, the agency said it will survey outsourcing facilities about challenges and opportunities related to market and business viability, compliance,…

Pfizer CEO Albert Bourla said Tuesday that uncertainty surrounding President Donald Trump’s proposed pharmaceutical tariffs is discouraging the company from making additional investments in U.S. manufacturing and research, CNBC News reported April 29.  Speaking to Pfizer’s first-quarter earnings, Mr. Bourla…